Alamar Biosciences (ALMR) Competitors

$20.06 0.00 (0.00%)

As of 05/22/2026 04:00 PM Eastern

ALMR vs. AVTR, MIR, VNT, AEHR, and TXG

Should you buy Alamar Biosciences stock or one of its competitors? MarketBeat compares Alamar Biosciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alamar Biosciences include Avantor (AVTR), Mirion Technologies (MIR), Vontier (VNT), Aehr Test Systems (AEHR), and 10x Genomics (TXG). These companies are all part of the "measuring and control equipment" industry.

How does Alamar Biosciences compare to Avantor?

Avantor (NYSE:AVTR) and Alamar Biosciences (NASDAQ:ALMR) are both measuring and control equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

Avantor currently has a consensus price target of $10.82, suggesting a potential upside of 33.52%. Alamar Biosciences has a consensus price target of $30.00, suggesting a potential upside of 49.55%. Given Alamar Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Alamar Biosciences is more favorable than Avantor.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avantor	2 Sell rating(s)	11 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Alamar Biosciences has lower revenue, but higher earnings than Avantor.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avantor	$6.55B	0.84	-$530.20M	-$0.81	N/A
Alamar Biosciences	$87.16M	15.95	N/A	N/A	N/A

Alamar Biosciences has a net margin of 0.00% compared to Avantor's net margin of -8.42%. Avantor's return on equity of 9.95% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avantor	-8.42%	9.95%	4.78%
Alamar Biosciences	N/A	N/A	N/A

95.1% of Avantor shares are owned by institutional investors. 0.3% of Avantor shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Avantor had 14 more articles in the media than Alamar Biosciences. MarketBeat recorded 15 mentions for Avantor and 1 mentions for Alamar Biosciences. Avantor's average media sentiment score of 0.44 beat Alamar Biosciences' score of 0.00 indicating that Avantor is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avantor	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alamar Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Avantor beats Alamar Biosciences on 7 of the 12 factors compared between the two stocks.

How does Alamar Biosciences compare to Mirion Technologies?

Alamar Biosciences (NASDAQ:ALMR) and Mirion Technologies (NYSE:MIR) are both measuring and control equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, institutional ownership, risk and profitability.

Alamar Biosciences currently has a consensus target price of $30.00, indicating a potential upside of 49.55%. Mirion Technologies has a consensus target price of $27.13, indicating a potential upside of 47.43%. Given Alamar Biosciences' higher possible upside, analysts plainly believe Alamar Biosciences is more favorable than Mirion Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Mirion Technologies	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80

Mirion Technologies has higher revenue and earnings than Alamar Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alamar Biosciences	$87.16M	15.95	N/A	N/A	N/A
Mirion Technologies	$925.40M	4.98	$28.80M	$0.10	183.98

In the previous week, Mirion Technologies had 4 more articles in the media than Alamar Biosciences. MarketBeat recorded 5 mentions for Mirion Technologies and 1 mentions for Alamar Biosciences. Mirion Technologies' average media sentiment score of 1.60 beat Alamar Biosciences' score of 0.00 indicating that Mirion Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alamar Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Mirion Technologies	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

78.5% of Mirion Technologies shares are owned by institutional investors. 6.3% of Mirion Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Mirion Technologies has a net margin of 2.56% compared to Alamar Biosciences' net margin of 0.00%. Mirion Technologies' return on equity of 6.44% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alamar Biosciences	N/A	N/A	N/A
Mirion Technologies	2.56%	6.44%	3.48%

Summary

Mirion Technologies beats Alamar Biosciences on 11 of the 13 factors compared between the two stocks.

How does Alamar Biosciences compare to Vontier?

Vontier (NYSE:VNT) and Alamar Biosciences (NASDAQ:ALMR) are both measuring and control equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability.

Vontier has a net margin of 13.37% compared to Alamar Biosciences' net margin of 0.00%. Vontier's return on equity of 37.88% beat Alamar Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vontier	13.37%	37.88%	10.90%
Alamar Biosciences	N/A	N/A	N/A

Vontier has higher revenue and earnings than Alamar Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vontier	$3.08B	1.36	$406.10M	$2.83	10.48
Alamar Biosciences	$87.16M	15.95	N/A	N/A	N/A

In the previous week, Vontier had 4 more articles in the media than Alamar Biosciences. MarketBeat recorded 5 mentions for Vontier and 1 mentions for Alamar Biosciences. Vontier's average media sentiment score of 0.96 beat Alamar Biosciences' score of 0.00 indicating that Vontier is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vontier	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alamar Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Vontier currently has a consensus price target of $42.38, indicating a potential upside of 42.91%. Alamar Biosciences has a consensus price target of $30.00, indicating a potential upside of 49.55%. Given Alamar Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Alamar Biosciences is more favorable than Vontier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vontier	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

95.8% of Vontier shares are held by institutional investors. 1.1% of Vontier shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Vontier beats Alamar Biosciences on 9 of the 12 factors compared between the two stocks.

How does Alamar Biosciences compare to Aehr Test Systems?

Alamar Biosciences (NASDAQ:ALMR) and Aehr Test Systems (NASDAQ:AEHR) are both measuring and control equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

Alamar Biosciences presently has a consensus price target of $30.00, suggesting a potential upside of 49.55%. Aehr Test Systems has a consensus price target of $68.00, suggesting a potential downside of 28.44%. Given Alamar Biosciences' stronger consensus rating and higher possible upside, equities research analysts plainly believe Alamar Biosciences is more favorable than Aehr Test Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Aehr Test Systems	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Aehr Test Systems had 2 more articles in the media than Alamar Biosciences. MarketBeat recorded 3 mentions for Aehr Test Systems and 1 mentions for Alamar Biosciences. Aehr Test Systems' average media sentiment score of 0.73 beat Alamar Biosciences' score of 0.00 indicating that Aehr Test Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alamar Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aehr Test Systems	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

69.7% of Aehr Test Systems shares are held by institutional investors. 6.8% of Aehr Test Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Alamar Biosciences has higher revenue and earnings than Aehr Test Systems.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alamar Biosciences	$87.16M	15.95	N/A	N/A	N/A
Aehr Test Systems	$58.97M	50.68	-$3.91M	-$0.38	N/A

Alamar Biosciences has a net margin of 0.00% compared to Aehr Test Systems' net margin of -25.23%. Alamar Biosciences' return on equity of 0.00% beat Aehr Test Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alamar Biosciences	N/A	N/A	N/A
Aehr Test Systems	-25.23%	-7.15%	-6.15%

Summary

Alamar Biosciences beats Aehr Test Systems on 7 of the 12 factors compared between the two stocks.

How does Alamar Biosciences compare to 10x Genomics?

10x Genomics (NASDAQ:TXG) and Alamar Biosciences (NASDAQ:ALMR) are both measuring and control equipment companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and institutional ownership.

10x Genomics presently has a consensus target price of $23.17, suggesting a potential downside of 2.17%. Alamar Biosciences has a consensus target price of $30.00, suggesting a potential upside of 49.55%. Given Alamar Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Alamar Biosciences is more favorable than 10x Genomics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
10x Genomics	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20
Alamar Biosciences	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Alamar Biosciences has a net margin of 0.00% compared to 10x Genomics' net margin of -3.55%. Alamar Biosciences' return on equity of 0.00% beat 10x Genomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
10x Genomics	-3.55%	-2.86%	-2.23%
Alamar Biosciences	N/A	N/A	N/A

84.7% of 10x Genomics shares are owned by institutional investors. 8.8% of 10x Genomics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Alamar Biosciences has lower revenue, but higher earnings than 10x Genomics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
10x Genomics	$642.82M	4.68	-$43.54M	-$0.17	N/A
Alamar Biosciences	$87.16M	15.95	N/A	N/A	N/A

In the previous week, 10x Genomics had 1 more articles in the media than Alamar Biosciences. MarketBeat recorded 2 mentions for 10x Genomics and 1 mentions for Alamar Biosciences. Alamar Biosciences' average media sentiment score of 0.00 beat 10x Genomics' score of -0.05 indicating that Alamar Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
10x Genomics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alamar Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Alamar Biosciences beats 10x Genomics on 7 of the 11 factors compared between the two stocks.

Get Alamar Biosciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALMR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALMR vs. The Competition

Export

Metric	Alamar Biosciences	Lab Analytical Instruments Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$1.39B	$1.39B	$4.26B	$12.34B
Dividend Yield	N/A	N/A	5.93%	5.28%
P/E Ratio	N/A	N/A	21.90	25.65
Price / Sales	15.95	15.95	180.55	86.31
Price / Cash	N/A	N/A	55.68	56.67
Price / Book	N/A	N/A	34.85	7.14
Net Income	N/A	N/A	$112.32M	$335.98M
7 Day Performance	-2.19%	-2.19%	3.52%	4.15%
1 Month Performance	-19.24%	-19.24%	3.56%	2.54%
1 Year Performance	N/A	N/A	15.78%	35.06%

Alamar Biosciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALMR Alamar Biosciences	4.3286 of 5 stars	$20.06 flat	$30.00 +49.6%	N/A	$1.39B	$87.16M	N/A	222	Quiet Period Expiration Gap Up
AVTR Avantor	4.3505 of 5 stars	$7.64 -3.8%	$10.82 +41.7%	-36.2%	$5.20B	$6.55B	8.96	13,500	Gap Down
MIR Mirion Technologies	4.176 of 5 stars	$18.17 -4.0%	$27.13 +49.3%	-2.7%	$4.55B	$925.40M	41.30	3,281	Positive News Gap Down
VNT Vontier	4.6512 of 5 stars	$28.04 -2.4%	$42.38 +51.1%	-16.0%	$3.95B	$3.08B	8.68	7,800	Dividend Announcement Buyback Announcement
AEHR Aehr Test Systems	2.0472 of 5 stars	$99.50 -6.4%	$68.00 -31.7%	+973.7%	$3.13B	$58.97M	N/A	90	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALMR) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alamar Biosciences (ALMR) Competitors

ALMR vs. AVTR, MIR, VNT, AEHR, and TXG

How does Alamar Biosciences compare to Avantor?

Summary

How does Alamar Biosciences compare to Mirion Technologies?

Summary

How does Alamar Biosciences compare to Vontier?

Summary

How does Alamar Biosciences compare to Aehr Test Systems?

Summary

How does Alamar Biosciences compare to 10x Genomics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALMR vs. The Competition

Alamar Biosciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alamar Biosciences (ALMR) Competitors

ALMR vs. AVTR, MIR, VNT, AEHR, and TXG

How does Alamar Biosciences compare to Avantor?

Do analysts recommend AVTR or ALMR?

Which has better earnings & valuation, AVTR or ALMR?

Is AVTR or ALMR more profitable?

Do insiders & institutionals hold more shares of AVTR or ALMR?

Does the media refer more to AVTR or ALMR?

Summary

How does Alamar Biosciences compare to Mirion Technologies?

Do analysts recommend ALMR or MIR?

Which has stronger earnings and valuation, ALMR or MIR?

Does the media refer more to ALMR or MIR?

Do institutionals and insiders believe in ALMR or MIR?

Is ALMR or MIR more profitable?

Summary

How does Alamar Biosciences compare to Vontier?

Is VNT or ALMR more profitable?

Which has preferable earnings & valuation, VNT or ALMR?

Does the media prefer VNT or ALMR?

Do analysts recommend VNT or ALMR?

Do insiders and institutionals believe in VNT or ALMR?

Summary

How does Alamar Biosciences compare to Aehr Test Systems?

Do analysts rate ALMR or AEHR?

Does the media prefer ALMR or AEHR?

Do institutionals & insiders hold more shares of ALMR or AEHR?

Which has higher earnings & valuation, ALMR or AEHR?

Is ALMR or AEHR more profitable?

Summary

How does Alamar Biosciences compare to 10x Genomics?

Do analysts recommend TXG or ALMR?

Is TXG or ALMR more profitable?

Do insiders & institutionals hold more shares of TXG or ALMR?

Which has stronger earnings & valuation, TXG or ALMR?

Does the media prefer TXG or ALMR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALMR vs. The Competition

Alamar Biosciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools